Real Stroke Reversal

It sounds crazy, but can someone who has been affected by a stroke experience a true stroke reversal, especially if it occurred years ago? You may say no, but hold your judgement until you see this 60 Minutes special because it’s truly amazing!!

According to the CDC, “Every year, more than 795,000 people in the United States have a stroke…killing about 140,000 Americans….and costing the United States an estimated $34 billion each year.”

So what’s the amazing antidote to create real stroke reversal?

Etanercept, whose trade name is Enbrel or Benepali.

Typically, etanercept is used to treat autoimmune diseases, like rheumatoid arthritis, but it has been found to be quite beneficial for stroke patients. There is a whole lot of science that goes along with this biopharmaceutical, but just know that it is a master regulator of inflammation, which includes inflammation of the brain.

Dr. Edward Tobinick of Boca Raton, FL administers the drug etanercept for neurological dysfunction after brain injury and stroke. He has seen amazing results in his patients, and now people who have suffered brain injury are coming to see him from all over the world. To learn more about him or to even make an appointment, visit Dr. Tobinick’s website. To watch this amazing stroke reversal, see the 60 Minutes feature below. What a story which gives so much hope to so many!!

Dr. Tobinick has written many articles about his findings. Sited below are some of his publications as collected on http://www.nrimed.com:

Selected Scientific Publications

• Perispinal Etanercept for Traumatic Brain Injury. Edward Tobinick MD, Rodriguez-Romanacce H, Kinssies R, Kim N. Chapter 7, pp. 109-29, in New Therapeutics for Traumatic Brain Injury, KA Heidenreich, editor. Cambridge, Mass.: Academic Press. 2017. (Link to Book Chapter).
• On Overcoming Barriers to Application of Neuroinflammation Research. Edward Tobinick MD, Ignatowski, T., Spengler, R. In: Abreu GEA, ed. Mechanisms of Neuroinflammation: InTechOpen; 2017. (FREE DOWNLOAD).
• Perispinal Delivery of CNS Drugs.  Edward Tobinick MD.  CNS Drugs, 2016;30(6):469-80. (FREE DOWNLOAD).
• Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence. Ignatowski TA, Spengler RN, Dhandapani KM, Folkersma H, Butterworth RF, Tobinick E. CNS Drugs 2014, doi: 10.1007/s40263-014-0174-2. (FREE DOWNLOAD).
• Immediate neurological recovery following perispinal etanercept years after brain injury. Edward Tobinick MD, Rodriguez-Romanacce H, Levine A, Ignatowski TA, Spengler RN. Clin Drug Investig. 2014 May;34(5):361-6. (Full text LINK).
• Selective TNF Inhibition for Chronic Stroke and Traumatic Brain Injury – An Observational Study Involving 629 Consecutive Patients Treated with Perispinal Etanercept. Edward Tobinick MD, Nancy M. Kim MD, Gary Reyzin MD, Helen Rodriguez ARNP, Venita DePuy, PhD. CNS Drugs. 2012 Dec;26(12):1051-70. (Link to Article).
• Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases. Edward Tobinick MD. CNS Drugs. 2011 Feb 1; 25(2):145-155. (Full text LINK).
• Perispinal Etanercept: A New Therapeutic Paradigm in Neurology. Edward Tobinick MD. Expert Review of Neurotherapeutics. 2010 Jun;10(6):985-1002. (FREE DOWNLOAD).
• Tumour necrosis factor modulation for treatment of Alzheimer’s disease: rationale and current evidence. Edward Tobinick MD. CNS Drugs. 2009 Sep 1;23(9):713-25. (Full text LINK).
• The value of drug repositioning in the current pharmaceutical market. Edward Tobinick MD. Drug News Perspect. 2009 Mar;22(2):119-25. Review. (Full text LINK).
• Rapid intracerebroventricular delivery of Cu-DOTA-etanercept after peripheral administration demonstrated by PET imaging. Edward Tobinick MD, K Chen PhD, X Chen PhD. BMC Res Notes. 2009 Feb 27;2:28. (FREE DOWNLOAD).
• Perispinal etanercept for neuroinflammatory disorders. Edward Tobinick MD. Drug Discovery Today. 2009 Feb;14(3-4):168-77. (Full text LINK).
• Perispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanism. Edward Tobinick MD. Medscape J Med. 2008 Jun 10;10(6):135. (Full text LINK).
• Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer’s disease. Edward Tobinick MD, H. Gross MD. BMC Neurology. 2008 Jul 21;8:27. (FREE DOWNLOAD).
• Re: Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Edward Tobinick MD. Neurology. 2008 Apr 1;70(14):1222-3.
• Perispinal etanercept for treatment of Alzheimer’s disease. Edward Tobinick MD. Current Alzheimer Research. 2007 Dec;4(5):550-2.
• A critique of intradiscal administration for treatment of radiculopathy. Edward Tobinick MD. Anesthesiology. 2008 Feb;108(2):334.
• Rapid cognitive improvement in Alzheimer’s disease following perispinal etanercept administration. Edward Tobinick MD, Hyman Gross MD. Journal of Neuroinflammation. 2008 Jan 9;5:2. (FREE DOWNLOAD)
• Spinal delivery of p38: TNF-alpha inhibitors. E Tobinick MD. PLoS Med. 2006 Nov;3(11):e511.
• TNF-alpha modulation for treatment of Alzheimer’s disease: a 6-month pilot study. Edward Tobinick MD, Hyman Gross MD, Alan Weinberger MD, Hart Cohen MD. MedGenMed. 2006 Apr 26;8(2):25.
• The cerebrospinal venous system: anatomy, physiology, and clinical implications. Edward Tobinick MD. MedGenMed. 2006 Feb 22;8(1):53.
• Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: a study of clinical observations in 143 patients. Edward Tobinick MD, Susan Davoodifar MD. Curr Med Res Opin. 2004 Jul;20(7):1075-85. (Link to Journal Article).
• Targeted etanercept for treatment-refractory pain due to bone metastasis: two case reports. Edward L. Tobinick MD. Clinical Therapeutics. 2003 Aug;25(8):2279-88.

**To learn about the 15 Ways to Improve Brain Health, check out our post here. Also, DMSO has been mentioned in some circles as a tool to minimize stroke during an event.